Ayala Pharmaceuticals, Inc. (ADXS)
(Delayed Data from OTC)
$0.10 USD
0.00 (0.00%)
Updated Sep 19, 2024 03:46 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Ayala Pharmaceuticals, Inc. [ADXS]
Reports for Purchase
Showing records 1 - 20 ( 96 total )
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
ADXS-HOT Readout in 2H19; Clinical Hold on AIM2CERV Lifted; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
ADXS-PSA and ADXS-NEO Show Promise at AACR, but Questions Remain; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Eyes on ADXS-NEO Data at AACR; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
ADXS-HOT Program Initiated in NSCLC; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
AXAL Placed Under Partial Clinical Hold; Expect Delays to AIM2CERV; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Eyes on ADXS-NEO Data in 1Q19; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Amgen Withdrawal Puts ADXS-NEO in Limbo; Downgrade to Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
AIM2CERV to Resume With Potential Readout in 2020; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
ADXS-NEO and ADXS-HOT Programs to Report in 2019; Lower $2.00PT on Dilution; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Eyes on ADXS-NEO and ADXS-HOT After Axal Withdrawal; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
A Strategic Shift to Focus on ADXS-NEO and ADXS-HOT; Lower PT to $3.00; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
ADXS-NEO Can Incite Immune Responses With "Non-Immunogenic" Antigens; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Clinical Hold Is Likely Temporary; Lower $6PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Three Notable Areas of Development in Companion Animal Health; Our Takeaways from VMX 2018
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
First Lm-LLO Product Approved for Pets; Looking Ahead to 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Management Reaffirms Development Strategy; Clinical Updates in 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Restructured to Focus on Lead Programs; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
A Wind of Change Is Blowing Through the Animal Health Market
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S